213 related articles for article (PubMed ID: 37235598)
1. Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
Bhattacharyya S; Vinkeles Melchers NVS; Siewe Fodjo JN; Vutha A; Coffeng LE; Logora MY; Colebunders R; Stolk WA
PLoS Negl Trop Dis; 2023 May; 17(5):e0011320. PubMed ID: 37235598
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey.
Colebunders R; Y Carter J; Olore PC; Puok K; Bhattacharyya S; Menon S; Abd-Elfarag G; Ojok M; Ensoy-Musoro C; Lako R; Logora MY
Seizure; 2018 Dec; 63():93-101. PubMed ID: 30468964
[TBL] [Abstract][Full Text] [Related]
3. The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Abd-Elfarag G; Logora MY; Carter JY; Ojok M; Songok J; Menon S; Wit F; Lako R; Colebunders R
Infect Dis Poverty; 2018 Nov; 7(1):112. PubMed ID: 30424817
[TBL] [Abstract][Full Text] [Related]
4. Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study.
Jada SR; Amaral LJ; Lakwo T; Carter JY; Rovarini J; Bol YY; Logora MY; Hadermann A; Hopkins A; Fodjo JNS; Colebunders R
Lancet Glob Health; 2023 Aug; 11(8):e1260-e1268. PubMed ID: 37474232
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan.
Colebunders R; Abd-Elfarag G; Carter JY; Olore PC; Puok K; Menon S; Fodjo Siewe JN; Bhattacharyya S; Ojok M; Lako R; Logora MY
Seizure; 2018 Nov; 62():108-115. PubMed ID: 30340162
[TBL] [Abstract][Full Text] [Related]
6. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on
Hadermann A; Jada SR; Sebit WJ; Deng T; Bol YY; Siewe Fodjo JN; De Coninck L; Matthijnssens J; Mertens I; Polman K; Colebunders R
F1000Res; 2023; 12():1262. PubMed ID: 38439783
[TBL] [Abstract][Full Text] [Related]
9. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
10. Population biology of human onchocerciasis.
Basáñez MG; Boussinesq M
Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
[TBL] [Abstract][Full Text] [Related]
13. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.
Colebunders R; Hendy A; Mokili JL; Wamala JF; Kaducu J; Kur L; Tepage F; Mandro M; Mucinya G; Mambandu G; Komba MY; Lumaliza JL; van Oijen M; Laudisoit A
BMC Res Notes; 2016 Mar; 9():182. PubMed ID: 27005304
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control.
Siewe Fodjo JN; Remme JHF; Preux PM; Colebunders R
Int Health; 2020 May; 12(3):192-202. PubMed ID: 32141502
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
16. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
17. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
18. Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
Colebunders R; Kaiser C; Basáñez MG; Olliaro P; Lakwo T; Siewe Fodjo JN
Int J Infect Dis; 2022 Mar; 116():302-305. PubMed ID: 35074518
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
20. Report of the first international workshop on onchocerciasis-associated epilepsy.
Colebunders R; Mandro M; Njamnshi AK; Boussinesq M; Hotterbeekx A; Kamgno J; O'Neill S; Hopkins A; Suykerbuyk P; Basáñez MG; Post RJ; Pedrique B; Preux PM; Stolk WA; Nutman TB; Idro R
Infect Dis Poverty; 2018 Mar; 7(1):23. PubMed ID: 29580280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
